The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
    • ACR ExamRheum
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Expert Says Vaccines Are Largely Safe for Rheumatology Patients

Expert Says Vaccines Are Largely Safe for Rheumatology Patients

July 18, 2019 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Marlon Lopez MMG1 Design / shutterstock.com

Marlon Lopez MMG1 Design / shutterstock.com

CHICAGO—Rheumatologists often come to Brian Schwartz, MD, associate professor of medicine and vice chief for clinical affairs in the Division of Infectious Diseases, University of California, San Francisco, with a concern: A patient on immunosuppression has a family member who needs a live vaccine, but the patient may be vulnerable to the vaccine’s effects. Should the family member get the vaccine?

You Might Also Like
  • Vaccines & Rheumatology Patients
  • ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
  • From the Expert: Don’t Forget to Vaccinate Immuncompromised Patients
Explore This Issue
July 2019
Also By This Author
  • EULAR 2013: Drugs New and Old Could Treat Spondylarthropies

The answer is yes, but precautions may be needed, Dr. Schwartz said during a session of the 2019 ACR State-of-the-Art Clinical Symposium, held April 5–7. His review of vaccinations in the context of rheumatic disease frequently touched on this theme: Vaccines are often advisable and safe for rheumatology patients—with caveats.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Family & Vaccines

In the case of a close family member getting a live vaccine, Dr. Schwartz said the benefits are worth it, even though “the person you’re most likely to get an infection from is probably the person you’re living with.”

“What I want to highly recommend—and recommend you to tell your patients—is that everybody in their family should get every vaccine that is recommended for them, because I really think a well-immunized family serves as a barrier to protect your patients from getting sick,” Dr. Schwartz said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

However, if a family member is getting a live influenza vaccine, the immunosuppressed person with rheumatic disease should avoid close contact. The patient should also be careful about contact with an infant who has just received a rotavirus vaccination, Dr. Schwartz said.

Effectiveness

Dr. Schwartz

Dr. Schwartz

When a rheumatologist is about to start a patient on treatment, it’s a good idea for patients and their physicians to consider vaccinations and think ahead, possibly holding off on starting a medication to ensure the vaccine can be effective, Dr. Schwartz noted.

“I want you to think about what you’re doing before you’re starting treatment, because that is the time you can get the most bang for your buck with a vaccine,” he said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

A 2017 study looking at flu vaccinations and methotrexate found patients who had methotrexate held for two weeks before the vaccine and for two weeks after, as well as those who had it held for four weeks after the vaccine, had a more robust response to the vaccine than patients who had methotrexate held for four weeks before or who didn’t have it held at all. However, at the last follow-up visit, patients who had methotrexate held during or after the vaccine experienced about triple the amount of flare—about 20%—compared with 7.5% for those who did not have it held.1

Findings such as these leave it up to a clinician’s judgment to determine whether the benefit of the vaccination is worth the heightened risk of flare, Dr. Schwartz said.

Dr. Schwartz also reminded the rheumatologists in the room about the widespread risk of flu. Although patients may say, “I never get the flu,” and think they don’t need the vaccine, the reality is 43 million symptomatic flu cases occurred in the U.S. in the 2017–2018 season, as well as almost a million hospitalizations and about 80,000 deaths. Patients need to know “there’s a good chance [they’re] going to be affected by this,” he said.

Rheumatology patients who get the flu would benefit from treatment with oseltamivir even if symptom onset is longer than two days—an exception to the rule of thumb that treatment is not beneficial after 48 hours.

“You’re still going to reduce the risk of having a bad outcome” in these particularly vulnerable patients, Dr. Schwartz said.

For patients with a family member with flu and with whom they’ve had close contact, a preventive dose of oseltamivir once a day rather than twice a day can be beneficial even if they’ve shown no symptoms.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Practice Management Tagged With: vaccination, vaccinesIssue: July 2019

You Might Also Like:
  • Vaccines & Rheumatology Patients
  • ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
  • From the Expert: Don’t Forget to Vaccinate Immuncompromised Patients
  • Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2019 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.